March 16, 2020 / 3:56 AM / 24 days ago

BRIEF-FDA Conducts Inspection At Alembic Pharmaceuticals' General Oral Solid Formulation Facility At Panelav

March 16 (Reuters) - Alembic Pharmaceuticals Ltd:

* U.S. FDA INSPECTION AT CO’S GENERAL ORAL SOLID FORMULATION FACILITY AT PANELAV

* U.S. FDA ISSUED FORM 483 WITH 4 PROCEDURAL OBSERVATIONS

* NONE OF U.S. FDA OBSERVATIONS ARE "RELATED TO DATA INTEGRITY" Source text: (bit.ly/3cZ6h9P) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below